Smart Materials and Devices for Stimuli-Responsive Drug Delivery: Advancing Precision Therapeutics
核心洞察
Smart materials and responsive devices adjust drug release in response to pH, temperature, enzymes, redox conditions, mechanical forces, or external triggers such as light, ultrasound, magnetic fields, and electrical stimulation.
These technologies aim to improve therapeutic precision, reduce side effects, and tailor treatments to individual patient needs.
Valuable progress in the field does not rely solely on highly complex systems, as many advances arise from simple design principles and practical device modifications.
Smart materials and responsive drug delivery devices represent an important evolution in biomedical engineering. Advances in polymers, hydrogels, nanocarriers, functional composites, and microfabrication have enabled systems that adjust their behavior in response to pH, temperature, enzymes, redox conditions, mechanical forces, or external triggers such as light, ultrasound, magnetic fields, and electrical stimulation. These technologies offer opportunities to improve therapeutic precision, reduce side effects, and tailor treatments to individual needs.
Importantly, impactful progress in this field does not rely solely on highly complex systems. Many valuable developments arise from simple design principles, improved material formulations, or practical device modifications that enhance reliability and performance.
The Shift Toward Responsive Delivery Platforms
Drug delivery systems are increasingly expected to provide improved precision, adaptability, and reliability. While passive release platforms remain widely used, there is growing interest in materials and devices that respond to biological or external cues to enhance therapeutic performance. The challenge is not only to develop highly sophisticated systems, but also to create practical and robust solutions that offer better control over timing, localization, and dosage, with a clear relationship between the trigger, responsive behavior, and delivery outcome.
Scope of the Research Topic
This Research Topic aims to gather contributions that advance smart, stimuli-responsive, or functionally adaptive drug delivery systems, spanning fundamental material development to applied device engineering. It focuses on systems in which a defined biological or external trigger produces a measurable and therapeutically relevant change in release, localization, retention, or delivery performance.
The collection welcomes studies demonstrating improved release behavior, enhanced stability, better targeting, or more predictable performance under physiologically relevant conditions. The goal is to highlight approaches—whether incremental or highly innovative—that meaningfully improve how therapeutics are delivered, monitored, or controlled. By bringing together diverse strategies, this collection will support the broader transition toward more responsive and effective drug delivery platforms.
Key Themes for Submission
The Research Topic provides a platform for both foundational and applied work that contributes to the growing toolbox of responsive drug delivery strategies. Relevant themes include trigger-controlled drug release in response to biological or external cues; material-device interfaces that connect sensing, actuation, and therapeutic delivery; externally activated platforms using light, ultrasound, magnetic fields, mechanical forces, or electrical stimulation; and functional composite and bio-inspired systems designed for adaptive or on-demand delivery.
Additional areas of interest include wearable, implantable, ingestible, textile-based, or microfabricated platforms with a defined responsive delivery function, as well as methods that quantify trigger-response behavior and its effect on release, localization, retention, or delivery performance.
Submission Types and Evaluation Criteria
The collection encourages original research, reviews, short communications, and perspectives. Submissions may address material development, mechanism studies, device engineering, release characterization, or early preclinical evaluation. Both incremental improvements and novel concepts are welcome. Studies should demonstrate a meaningful responsive function or trigger-controlled delivery benefit.
